CA2405710A1 - Method and apparatus for creating intrauterine adhesions - Google Patents
Method and apparatus for creating intrauterine adhesions Download PDFInfo
- Publication number
- CA2405710A1 CA2405710A1 CA002405710A CA2405710A CA2405710A1 CA 2405710 A1 CA2405710 A1 CA 2405710A1 CA 002405710 A CA002405710 A CA 002405710A CA 2405710 A CA2405710 A CA 2405710A CA 2405710 A1 CA2405710 A1 CA 2405710A1
- Authority
- CA
- Canada
- Prior art keywords
- implantable device
- marker
- trauma
- uterus
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/0063—Implantable repair or support meshes, e.g. hernia meshes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/42—Gynaecological or obstetrical instruments or methods
- A61B17/4241—Instruments for manoeuvring or retracting the uterus, e.g. during laparoscopic surgery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/42—Gynaecological or obstetrical instruments or methods
- A61B2017/4216—Operations on uterus, e.g. endometrium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/103—Detecting, measuring or recording devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
- A61B5/107—Measuring physical dimensions, e.g. size of the entire body or parts thereof
- A61B5/1076—Measuring physical dimensions, e.g. size of the entire body or parts thereof for measuring dimensions inside body cavities, e.g. using catheters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment
- A61B6/12—Devices for detecting or locating foreign bodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/08—Detecting organic movements or changes, e.g. tumours, cysts, swellings
- A61B8/0833—Detecting organic movements or changes, e.g. tumours, cysts, swellings involving detecting or locating foreign bodies or organic structures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/0063—Implantable repair or support meshes, e.g. hernia meshes
- A61F2002/0072—Delivery tools therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/0067—Means for introducing or releasing pharmaceutical products into the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
- A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
Abstract
An apparatus and method of use or treatment are disclosed for creating intrauterine adhesions resulting in amenorrhea. In particular, the apparatus relates to an easily deployed intrauterine implant that readily and consistently reduces or eliminates abnormal intrauterine bleeding. In addition, the apparatus is also used as a uterine marker device for visualizing endometrial tissue thickness and potential changes. The method o f the present invention serves as a supplement to or a replacement for conventional hysterectomy or ablation/resection procedures used to treat menorrhagia.
Claims (110)
1. An implantable device for treating excessive bleeding in a body cavity, comprising:
a biocompatible material deliverable into said body cavity;
said biocompatible material containing an attribute promoting tissue growth that results in adhesion formation within said body cavity;
said attribute defined by at least one of a mechanical component of said biocompatible material and a non-cultured biologic component of said biocompatible material.
a biocompatible material deliverable into said body cavity;
said biocompatible material containing an attribute promoting tissue growth that results in adhesion formation within said body cavity;
said attribute defined by at least one of a mechanical component of said biocompatible material and a non-cultured biologic component of said biocompatible material.
2. The implantable device of claim 1 wherein said material is shaped to conform to an internal structure of a body cavity.
3. The implantable device of claim 2 wherein said body cavity is a uterus.
4. The implantable device of claim 1 wherein said material is sterile and flexible.
5. The implantable device of claim 1 wherein said material is substantially rigid.
6. The implantable device of claim 1 wherein said material is selected from the group consisting of mesh, suture, gel, porous, allograft, protein, hydrogel, liquid sealant, glue, cellulose, collagen, sponge, micro-porous, tissue/collagen, thrombin, alginate, tissue, kitosan, particulate, foam and any combination thereof.
7. The implantable device of claim 6 wherein a structure of said mesh is selected from the group consisting of woven, non-woven, braided, spun, knitted and any combination thereof.
8. The implantable device of claim 1 wherein said material is metallic.
9. The implantable device of claim 1 wherein said material is polymeric.
10. The implantable device of claim 1 wherein said material is a bio-material.
11. The implantable device of claim 1 wherein said material has a characteristic selected from the group consisting of non-absorbable, absorbable and resorbable.
12. The implantable device of claim 6 wherein a weave of said mesh selected from the group consisting of plain, open, closed, twill, dutch, reverse dutch, twill dutch, teffeta and any combination thereof.
13. The implantable device of claim 1 wherein said material is a random fiber bundle.
14. The implantable device of claim 13 wherein said material is fabricated from a monofilament.
15. The implantable device of claim 13 wherein said material is fabricated from a multi-filament.
16. The implantable device of claim 6 wherein said porous material is selected from the group consisting of ceramics, alumina, silicon, powdered metals, Nitinol®, stainless steel, titanium, porous polymers and any combination thereof.
17. The implantable device of claim 1 wherein said material is further incorporated into a mesh matrix.
18. The implantable device of claim 6 wherein a pore size of said porous material is less than 10 microns.
19. The implantable device of claim 6 wherein a pore size of said porous material is greater than 75 microns.
20. The implantable device of claim 6 wherein said liquid sealant or glue is one selected from the group consisting of thrombin, collagen-thrombin, polymer, collagen, fibrin-based and any combination thereof.
21. The implantable device of claim 6 wherein said liquid sealant forms a hemostatic solid.
22. The implantable device of claim 6 wherein said protein is configured into a format, whereby said format is selected from the group consisting of small beads, sheets, strips, regular shaped configurations and irregular shaped configurations.
23. The implantable device of claim 6 wherein said material comprises mesh particles.
24. The implantable device of claim 23 wherein said mesh particles are configured into a form selected form the group consisting of atomized micro-particles, semi-rigid foam, suspended aggregate, particulates, powder and any combination thereof.
25. The implantable device of claim 23 wherein said mesh particulates are suspended in a substance selected from the group consisting of liquid, gas, foam and flowable substance.
26. The implantable device of claim 1 wherein said material is encapsulated in a hydrophillic membrane.
27. The implantable device of claim 1 wherein said material is self-expanding.
28. The implantable device of claim 1 further comprising one or more coatings, wherein said coating is imaged using an imaging technique.
29. The implantable device of claim 28 wherein said coating is dissolvable.
30. A method of creating adhesions in a body cavity comprising:
inserting an implantable device within said body cavity; and locating said device at an optimal site within said body cavity, wherein said optimal site promotes effective adhesion formation to control bleeding.
inserting an implantable device within said body cavity; and locating said device at an optimal site within said body cavity, wherein said optimal site promotes effective adhesion formation to control bleeding.
31. The method of claim 30 further comprising determining an optimal site in said body cavity that is a site of excessive bleeding.
32. The method of claim 30 further comprising removing said implantable device after sufficient adhesions have formed.
33. The method of claim 30 further comprising pretreating said body cavity prior to inserting said implantable device within said body cavity.
34. The method of claim 33 wherein said pretreating includes creating trauma to a tissue within said body cavity.
35. The method of claim 34 wherein said trauma includes necrosis of said tissue.
36. The method of claim 34 wherein said trauma is achieved via ablation.
37. The method of claim 34 wherein said trauma is achieved via curettage.
38. The method of claim 34 wherein said trauma is achieved via liquid abrasion.
39. The method of claim 33 wherein said pretreating is performed using a device selected from the group consisting of curette, roller ball electrocautery device, thermal energy device, hot water filled balloon; radio-frequency (RF) energy director, microwave, cryogenic device, cytotoxic agent, intense LASER light, devices capable of imparting trauma to the endometrial lining and any combination thereof.
40. The method of claim 33 wherein said pretreating involves the use of a drug.
41. The method of claim 40 wherein said drug is one selected from the group consisting of hormones, hormone-altering medications and antibiotics.
42. The method of claim 33 wherein said pretreating involves the use of a chemical.
43. The method of claim 33 further comprising timing said pretreating to a patient's normal menstrual cycle.
44. The method of claim 30 further comprising pretreating said body cavity when an endometrium is in an optimal state for adhesion formation.
45. The method of claim 30 further comprising post-treating said body cavity after inserting said implantable device within said body cavity and forming adhesions.
46. The method of claim 45 wherein said post-treating involves the use of a drug.
47. The method of claim 46 wherein said drug is one selected from the group consisting of hormones or chemicals.
48. A pretreatment device for creating trauma to a tissue within a body cavity comprising:
a stem section; and a trauma-inducing section adjacent said stem section.
a stem section; and a trauma-inducing section adjacent said stem section.
49. The device of claim 48 wherein said trauma-inducing section consists of bristles.
50. The device of claim 48 wherein said trauma-inducing section consists of spike-like projections.
51. The device of claim 48 wherein said stem section is made of a material selected from the group consisting of rigid polymers, ABS, nylon, PVC, stainless steel, aluminum, metallics and any combination thereof.
52. The device of claim 48 wherein said trauma-inducing section is made of a material selected from the group consisting of semi-rigid polymers, nylon, polyethylene and any combination thereof.
53. The device of claim 48 wherein said trauma-inducing section is configured as a Brillo® pad-like structure capable of scouring tissue.
54. The device of claim 53 wherein said Brillo® pad-like structure is comprised of collagen coated with a sclerosing agent.
55. The device of claim 53 wherein said Brillo® pad-like structure can self-expand when deployed from a catheter.
56. The device of claim 48 wherein said trauma-inducing section comprises a multi-pronged brush.
57. The device of claim 48 wherein said trauma-inducing section comprises a wire with sharp protrusions.
58. The device of claim 48 wherein said trauma-inducing section comprises a cap.
59. The device of claim 48 wherein said trauma-inducing section comprises a collagen plug.
60. The device of claim 48 wherein said trauma-inducing section comprises a wire-formed distal end.
61. The device of claim 60 wherein said distal end is comprised of one or more fibers configured to form an egg-beater design.
62. The device of claim 60 wherein said wires are fabricated from a material selected from the group consisting of Nitinol®, stainless steel, titanium and any combination thereof.
63. The device of claim 60 wherein said trauma-inducing section comprises a balloon having a rough external surface.
64. The device of claim 63 wherein said surface includes fine wires.
65. The device of claim 64 wherein said surface includes small bristles.
66. A pretreatment device for creating trauma to a tissue within a body cavity comprising:
a pretreatment fluid; and a tube housed within a catheter and used to insult said tissue with said pretreatment fluid.
a pretreatment fluid; and a tube housed within a catheter and used to insult said tissue with said pretreatment fluid.
67. The device of claim 66 wherein said fluid is a crystalline salt suspended in a water stream.
68. A method of contraception comprising:
inserting an implantable device within a uterus; and locating said device at an optimal site within said uterus, wherein said optimal site promotes adhesion formation and prevents conception.
inserting an implantable device within a uterus; and locating said device at an optimal site within said uterus, wherein said optimal site promotes adhesion formation and prevents conception.
69. A tool used to deploy an implantable device within a uterus comprising:
a cervical cap; and a guide located on a proximal end of said cervical cap.
a cervical cap; and a guide located on a proximal end of said cervical cap.
70. The tool of claim 69 wherein said cervical cap includes a one-way valve having one or more slits on said valve.
71. The tool of claim 69 wherein said cervical cap forms a cup-shaped device.
72. The tool of claim 69 wherein said guide comprises a hollow tube.
73. The tool of claim 69 wherein said guide comprises a catheter.
74. The tool of claim 69 wherein said cap includes one or more lumen for dispensing fluid, creating vacuum, delivering tools and deploying said implantable device.
75. The tool of claim 69 further comprising a speculum used to dilate a vagina.
76. A tool used to deploy an implantable device within a uterus comprising:
one or more expanding elements attached to said implantable device;
and one or more manipulator elements.
one or more expanding elements attached to said implantable device;
and one or more manipulator elements.
77. The tool of claim 76 wherein said expanding element is one selected from the group consisting of rigid lumen, elastic membrane, wire, balloon and inflatable tube.
78. The tool of claim 76 wherein said manipulator element is one selected from the group consisting of hook, wire, string, monofilament, spring, hinge and inflation lumen.
79. The tool of claim 76 wherein said expanding element is a wire attached to said implantable device via a one-way barb.
80. A tool used to deploy an implantable device comprising:
a guide directed for placement of said implantable device within a uterus to create adhesions.
a guide directed for placement of said implantable device within a uterus to create adhesions.
81. The tool of claim 80 wherein said guide is permanently implanted within a patient.
82. The tool of claim 80 wherein said guide forms a pathway to a cervix of a patient.
83. The tool of claim 80 wherein said guide comprises a hollow tube.
84. A device for monitoring the tissue of a uterus comprising:
at least one imagable marker;
said marker having a size less than a size of an expanded uterus;
said marker having a surface for adhering said marker to a uterine wall;
said marker composed of a biocompatible material suitable for permanent implantation in said uterus; and said marker detachably disposed on a delivery tool prior to insertion of said marker into said uterus.
at least one imagable marker;
said marker having a size less than a size of an expanded uterus;
said marker having a surface for adhering said marker to a uterine wall;
said marker composed of a biocompatible material suitable for permanent implantation in said uterus; and said marker detachably disposed on a delivery tool prior to insertion of said marker into said uterus.
85. The device of claim 84 wherein said marker is imagable using an imaging technique selected from the group consisting of ultrasound, magnetic resonance imaging, computed tomography, x-ray and an y combination thereof.
86. The device of claim 84 wherein said marker is incorporated into an implant device.
87. The device of claim 84 wherein said marker is incorporated into a deployment tool.
88. The device of claim 84 wherein said marker is incorporated into a pretreatment device.
89. The device of claim 84 wherein said size is adjustable.
90. The device of claim 84 wherein said size corresponds to one of a predetermined range of uterus sizes.
91. The device of claim 84 further including a shape, wherein said shape is adjustable.
92. The device of claim 91 wherein said shape is selected from the group consisting of sphere, tube, donut, hollow sphere, equilateral triangular shape, curved object and other geometric shapes.
93. The device of claim 84 wherein said marker has a density different from a density of surrounding tissue.
94. The device of claim 84 wherein said material of said marker is selected form the group consisting of polypropylene, ethylene, titanium, urethane, nylon, GORE-TEX®, PTFE, Nitinol®, stainless steel, proteins, or any type of human biologic that is stabile.
95. The device of claim 94 wherein said material is a combination of materials.
96. The device of claim 84 wherein said marker is configured as a solid component.
97. The device of claim 84 wherein said marker is configured as a hollow component.
98. The device of claim 97 wherein said hollow component is filled with a liquid.
99. The device of claim 97 wherein said hollow component is filled with a gas.
100. The device of claim 84 further comprising a substance coated on an exterior portion of said marker.
101. The device of claim 100 wherein said substance is a biological material.
102. The device of claim 101 wherein said substance is reactive to tissues.
103. The device of claim 101 wherein said substance is reactive to cells.
104. The device of claim 100 wherein said biological material prevents liquid/moisture penetration.
105. A method of monitoring tissue of a uterus comprising:
introducing at least one imagable marker into an interior of said uterus;
allowing said at least one marker to become embedded in tissue formed on said interior of said uterus; and using said at least one marker as a reference location to evaluate tissue features on said interior of said uterus.
introducing at least one imagable marker into an interior of said uterus;
allowing said at least one marker to become embedded in tissue formed on said interior of said uterus; and using said at least one marker as a reference location to evaluate tissue features on said interior of said uterus.
106. The method of claim 105 wherein at least two imagable markers are introduced into said uterus and wherein said at least two markers provide a two dimensional frame of reference.
107. The method of claim 105 wherein said at least one imagable marker is introduced into said interior during a procedure wherein said uterus is being treated for a condition of menorrhagia.
108. The method of claim 105 wherein said at least one imagable marker is allowed to remain in said uterus for an extended period of time.
109. The method of claim 105 further comprising determining placement of an implantable device, wherein said implantable device is combined with said marker.
110. The method of claim 105 further comprising imaging said marker using common imaging techniques.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US19973600P | 2000-04-25 | 2000-04-25 | |
US60/199,736 | 2000-04-25 | ||
US25652900P | 2000-12-18 | 2000-12-18 | |
US60/256,529 | 2000-12-18 | ||
PCT/US2001/013169 WO2001080788A2 (en) | 2000-04-25 | 2001-04-24 | Method and apparatus for creating intrauterine adhesions |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2405710A1 true CA2405710A1 (en) | 2001-11-01 |
CA2405710C CA2405710C (en) | 2010-04-20 |
Family
ID=26895094
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2405710A Expired - Lifetime CA2405710C (en) | 2000-04-25 | 2001-04-24 | Method and apparatus for creating intrauterine adhesions |
Country Status (6)
Country | Link |
---|---|
US (5) | US6708056B2 (en) |
EP (1) | EP1278480A2 (en) |
JP (3) | JP4503208B2 (en) |
AU (2) | AU2001257212B9 (en) |
CA (1) | CA2405710C (en) |
WO (1) | WO2001080788A2 (en) |
Families Citing this family (151)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050031662A1 (en) * | 2001-04-24 | 2005-02-10 | Impres Medical, Inc. | Bioreactive methods and devices for treating uterine bleeding |
EP1278480A2 (en) * | 2000-04-25 | 2003-01-29 | Impres Medical, Inc. | Method and apparatus for creating intrauterine adhesions |
US6685626B2 (en) | 2001-02-02 | 2004-02-03 | Regeneration Technologies, Inc. | Compositions, devices, methods, and kits for induction of adhesions |
GB0108088D0 (en) * | 2001-03-30 | 2001-05-23 | Browning Healthcare Ltd | Surgical implant |
EP1545390A4 (en) * | 2002-08-23 | 2007-05-09 | Proxy Biomedical Ltd | Three dimensional implant |
DE60331854D1 (en) * | 2002-11-07 | 2010-05-06 | Abbott Lab | METHOD FOR ATTACHING A MEDICAMENT TO A PROSTHESIS BY MEANS OF A LIQUID AMOUNT |
WO2004093793A2 (en) * | 2003-04-16 | 2004-11-04 | Ablation Products Llc | Delivery vehicle for silver ions |
US20050033157A1 (en) * | 2003-07-25 | 2005-02-10 | Klein Dean A. | Multi-modality marking material and method |
US8579892B2 (en) | 2003-10-07 | 2013-11-12 | Tsunami Medtech, Llc | Medical system and method of use |
NZ548679A (en) | 2003-12-22 | 2009-11-27 | Ams Res Corp | Cryosurgical devices and methods for endometrial ablation |
US20050240211A1 (en) * | 2004-04-21 | 2005-10-27 | Stefan Sporri | Apparatus and method for selectably treating a fallopian tube |
US20060089658A1 (en) * | 2004-10-21 | 2006-04-27 | Harrington Douglas C | Method and apparatus for treating abnormal uterine bleeding |
US8181653B2 (en) | 2005-02-15 | 2012-05-22 | Yale University | Intrauterine fallopian tube occlusion device |
US8662081B2 (en) | 2005-02-15 | 2014-03-04 | Yale University | Intrauterine device |
US20060200250A1 (en) * | 2005-03-04 | 2006-09-07 | Ku David N | Biocompatible implant device |
US7942873B2 (en) * | 2005-03-25 | 2011-05-17 | Angiodynamics, Inc. | Cavity ablation apparatus and method |
FI123188B (en) * | 2005-04-05 | 2012-12-14 | Bayer Oy | Ultrasonically detectable intrauterine system |
WO2007030002A1 (en) * | 2005-09-07 | 2007-03-15 | Gynaecologiq B.V. | Sealing stopper and assembly comprising such a sealing stopper |
US7878970B2 (en) * | 2005-09-28 | 2011-02-01 | Boston Scientific Scimed, Inc. | Apparatus and method for suspending a uterus |
US9144483B2 (en) * | 2006-01-13 | 2015-09-29 | Boston Scientific Scimed, Inc. | Placing fixation devices |
US9078727B2 (en) * | 2006-03-16 | 2015-07-14 | Boston Scientific Scimed, Inc. | System and method for treating tissue wall prolapse |
US8235047B2 (en) | 2006-03-30 | 2012-08-07 | Conceptus, Inc. | Methods and devices for deployment into a lumen |
WO2007140278A2 (en) * | 2006-05-24 | 2007-12-06 | Rush University Medical Center | High temperature thermal therapy of breast cancer |
US9414883B2 (en) * | 2006-06-09 | 2016-08-16 | Boston Scientific Scimed, Inc. | Co-access foam/electrode introducer |
JP2010506627A (en) * | 2006-10-12 | 2010-03-04 | インプレス メディカル, インコーポレイテッド | Method and apparatus for occluding a lumen |
US8840625B2 (en) | 2006-10-18 | 2014-09-23 | Hologic, Inc. | Systems for performing gynecological procedures with closed visualization lumen |
CN100423792C (en) * | 2006-10-26 | 2008-10-08 | 上海交通大学医学院附属新华医院 | Slow release type testis prosthesis and its application |
US8025656B2 (en) * | 2006-11-07 | 2011-09-27 | Hologic, Inc. | Methods, systems and devices for performing gynecological procedures |
US20080146872A1 (en) * | 2006-11-07 | 2008-06-19 | Gruber William H | Mechanical distension systems for performing a medical procedure in a remote space |
US8574253B2 (en) * | 2007-04-06 | 2013-11-05 | Hologic, Inc. | Method, system and device for tissue removal |
US20090270898A1 (en) * | 2007-04-06 | 2009-10-29 | Interlace Medical, Inc. | Tissue removal device with high reciprocation rate |
US9259233B2 (en) * | 2007-04-06 | 2016-02-16 | Hologic, Inc. | Method and device for distending a gynecological cavity |
US9095366B2 (en) | 2007-04-06 | 2015-08-04 | Hologic, Inc. | Tissue cutter with differential hardness |
US8216217B2 (en) * | 2007-08-23 | 2012-07-10 | Aegea Medical, Inc. | Uterine therapy device and method |
US8100129B2 (en) * | 2007-08-28 | 2012-01-24 | Conceptus, Inc. | Methods and devices for occluding an ovarian pathway |
US20090076411A1 (en) * | 2007-09-17 | 2009-03-19 | Syed Rizvi | Endometrial anesthesia delivery device and methods of use thereof |
CN101902980A (en) * | 2007-11-14 | 2010-12-01 | 新波医药系统股份有限公司 | Effect of radiofrequency fields on cell growth and methods for laparoscopic treatment |
US9282958B2 (en) * | 2007-12-28 | 2016-03-15 | Boston Scientific Scimed, Inc. | Devices and method for treating pelvic dysfunctions |
US8430807B2 (en) | 2007-12-28 | 2013-04-30 | Boston Scientific Scimed, Inc. | Devices and methods for treating pelvic floor dysfunctions |
US9078728B2 (en) * | 2007-12-28 | 2015-07-14 | Boston Scientific Scimed, Inc. | Devices and methods for delivering female pelvic floor implants |
US8317808B2 (en) | 2008-02-18 | 2012-11-27 | Covidien Lp | Device and method for rolling and inserting a prosthetic patch into a body cavity |
AU2009215269B2 (en) | 2008-02-18 | 2013-01-31 | Covidien Lp | A device and method for deploying and attaching a patch to a biological tissue |
US8758373B2 (en) | 2008-02-18 | 2014-06-24 | Covidien Lp | Means and method for reversibly connecting a patch to a patch deployment device |
US9398944B2 (en) | 2008-02-18 | 2016-07-26 | Covidien Lp | Lock bar spring and clip for implant deployment device |
US9393093B2 (en) | 2008-02-18 | 2016-07-19 | Covidien Lp | Clip for implant deployment device |
US9034002B2 (en) | 2008-02-18 | 2015-05-19 | Covidien Lp | Lock bar spring and clip for implant deployment device |
US8808314B2 (en) | 2008-02-18 | 2014-08-19 | Covidien Lp | Device and method for deploying and attaching an implant to a biological tissue |
US9301826B2 (en) | 2008-02-18 | 2016-04-05 | Covidien Lp | Lock bar spring and clip for implant deployment device |
US9393002B2 (en) | 2008-02-18 | 2016-07-19 | Covidien Lp | Clip for implant deployment device |
US9833240B2 (en) | 2008-02-18 | 2017-12-05 | Covidien Lp | Lock bar spring and clip for implant deployment device |
US9044235B2 (en) | 2008-02-18 | 2015-06-02 | Covidien Lp | Magnetic clip for implant deployment device |
US8282612B1 (en) | 2008-03-07 | 2012-10-09 | Denise H. Miller | Methods and devices for intrauterine absorption |
US20090240164A1 (en) * | 2008-03-18 | 2009-09-24 | Alexandra Jean Gillespie | Device and Method for Collecting Tissue Samples |
US8764630B2 (en) * | 2008-05-19 | 2014-07-01 | Olympus Medical Systems Corp. | Endoscopic surgical procedure and surgical apparatus |
RU2532389C2 (en) * | 2008-09-02 | 2014-11-10 | ЭБЛЭЙШН ПРОДАКТС ЭлЭлСи | Platform for silver ion delivery |
US10064697B2 (en) | 2008-10-06 | 2018-09-04 | Santa Anna Tech Llc | Vapor based ablation system for treating various indications |
US9700365B2 (en) | 2008-10-06 | 2017-07-11 | Santa Anna Tech Llc | Method and apparatus for the ablation of gastrointestinal tissue |
US9561066B2 (en) | 2008-10-06 | 2017-02-07 | Virender K. Sharma | Method and apparatus for tissue ablation |
US9561068B2 (en) | 2008-10-06 | 2017-02-07 | Virender K. Sharma | Method and apparatus for tissue ablation |
US10695126B2 (en) | 2008-10-06 | 2020-06-30 | Santa Anna Tech Llc | Catheter with a double balloon structure to generate and apply a heated ablative zone to tissue |
EP2792307B1 (en) | 2008-10-20 | 2017-10-04 | Covidien LP | A device for attaching a patch to a biological tissue |
US8545513B2 (en) * | 2008-10-24 | 2013-10-01 | Coopersurgical, Inc. | Uterine manipulator assemblies and related components and methods |
US8356600B2 (en) * | 2008-11-11 | 2013-01-22 | Conceptus, Inc. | Occlusion implant |
EP2387383B1 (en) * | 2009-01-18 | 2017-03-22 | Ocon Medical Ltd | Novel intra uterine device |
SI2381932T1 (en) * | 2009-01-29 | 2018-12-31 | Fondazione Irccs Instituto Nazionale Dei Tumori | Intra-cervical device for the release of drugs in the local- regional treatment of cervical cancer |
US11284931B2 (en) | 2009-02-03 | 2022-03-29 | Tsunami Medtech, Llc | Medical systems and methods for ablating and absorbing tissue |
WO2010117908A1 (en) * | 2009-04-06 | 2010-10-14 | University Of Virginia Patent Foundation | Anisotropic reinforcement and related method thereof |
US9125716B2 (en) * | 2009-04-17 | 2015-09-08 | Boston Scientific Scimed, Inc. | Delivery sleeve for pelvic floor implants |
US11903602B2 (en) | 2009-04-29 | 2024-02-20 | Hologic, Inc. | Uterine fibroid tissue removal device |
US20100298757A1 (en) * | 2009-05-19 | 2010-11-25 | Ams Research Corporation | Adjuvant enhanced ablation |
WO2011021083A1 (en) | 2009-08-17 | 2011-02-24 | PolyTouch Medical, Inc. | Articulating patch deployment device and method of use |
EP3508144B1 (en) | 2009-08-17 | 2021-04-07 | Covidien LP | Patch deployment device |
US9044580B2 (en) | 2009-08-24 | 2015-06-02 | Arsenal Medical, Inc. | In-situ forming foams with outer layer |
US9173817B2 (en) | 2009-08-24 | 2015-11-03 | Arsenal Medical, Inc. | In situ forming hemostatic foam implants |
US8721621B2 (en) * | 2009-09-10 | 2014-05-13 | Taris Biomedical, Inc. | Systems and methods for deploying devices to genitourinary sites |
US8470355B2 (en) * | 2009-10-01 | 2013-06-25 | Covidien Lp | Mesh implant |
CN102741336B (en) | 2009-12-01 | 2014-03-19 | 株式会社普利司通 | Modified rubber compositions and methods of preparation |
US20120330132A1 (en) * | 2009-12-07 | 2012-12-27 | Paul Sorajja | Device for the Delineation of Cardiovascular or Other Anatomical Structures |
US9138210B2 (en) * | 2010-05-11 | 2015-09-22 | Ethicon Endo-Surgery, Inc. | Fistula cleaning and repair device and method |
US8936592B2 (en) | 2010-06-03 | 2015-01-20 | Ams Research Corporation | Laser tissue ablation system |
FR2962646B1 (en) | 2010-07-16 | 2012-06-22 | Sofradim Production | PROSTHETIC WITH RADIO OPAQUE ELEMENT |
US8834418B2 (en) | 2010-07-22 | 2014-09-16 | Covidien Lp | Molds for in situ forming materials |
US9943353B2 (en) | 2013-03-15 | 2018-04-17 | Tsunami Medtech, Llc | Medical system and method of use |
US9180039B2 (en) | 2010-08-16 | 2015-11-10 | Yale University | Intrauterine device |
US9475709B2 (en) | 2010-08-25 | 2016-10-25 | Lockheed Martin Corporation | Perforated graphene deionization or desalination |
US8911348B2 (en) | 2010-09-02 | 2014-12-16 | Boston Scientific Scimed, Inc. | Pelvic implants and methods of implanting the same |
US8939988B2 (en) | 2010-11-01 | 2015-01-27 | Coopersurgical, Inc. | Uterine manipulators and related components and methods |
WO2012064864A1 (en) | 2010-11-09 | 2012-05-18 | Aegea Medical Inc. | Positioning method and apparatus for delivering vapor to the uterus |
US8876804B2 (en) | 2010-12-17 | 2014-11-04 | Ams Research Corporation | Ablation device |
US9655557B2 (en) * | 2011-02-04 | 2017-05-23 | Minerva Surgical, Inc. | Methods and systems for evaluating the integrity of a uterine cavity |
WO2012170380A2 (en) * | 2011-06-07 | 2012-12-13 | Linnemeier Georgiann C | Method for the early detection of high-grade pelvic serous cancer |
US9220887B2 (en) | 2011-06-09 | 2015-12-29 | Astora Women's Health LLC | Electrode lead including a deployable tissue anchor |
FR2977790B1 (en) | 2011-07-13 | 2013-07-19 | Sofradim Production | PROSTHETIC FOR UMBILIC HERNIA |
US8579924B2 (en) | 2011-07-26 | 2013-11-12 | Covidien Lp | Implantable devices including a mesh and a pivotable film |
US9168120B2 (en) | 2011-09-09 | 2015-10-27 | Boston Scientific Scimed, Inc. | Medical device and methods of delivering the medical device |
US9662060B2 (en) | 2011-10-07 | 2017-05-30 | Aegea Medical Inc. | Integrity testing method and apparatus for delivering vapor to the uterus |
US8993831B2 (en) * | 2011-11-01 | 2015-03-31 | Arsenal Medical, Inc. | Foam and delivery system for treatment of postpartum hemorrhage |
US10064651B2 (en) | 2012-03-15 | 2018-09-04 | Inpress Technologies, Inc. | Uterine hemorrhage controlling system and method |
US9550014B2 (en) * | 2012-03-15 | 2017-01-24 | Inpress Technologies, Inc. | Postpartum uterine contractile apparatus and method |
CN102657546B (en) * | 2012-05-16 | 2014-05-28 | 段华 | Carrier barrier system applied to prevention and treatment of metrosynizesis |
US10418143B2 (en) | 2015-08-05 | 2019-09-17 | Lockheed Martin Corporation | Perforatable sheets of graphene-based material |
US9744617B2 (en) | 2014-01-31 | 2017-08-29 | Lockheed Martin Corporation | Methods for perforating multi-layer graphene through ion bombardment |
US10376845B2 (en) | 2016-04-14 | 2019-08-13 | Lockheed Martin Corporation | Membranes with tunable selectivity |
US10653824B2 (en) | 2012-05-25 | 2020-05-19 | Lockheed Martin Corporation | Two-dimensional materials and uses thereof |
US9610546B2 (en) | 2014-03-12 | 2017-04-04 | Lockheed Martin Corporation | Separation membranes formed from perforated graphene and methods for use thereof |
US9834809B2 (en) | 2014-02-28 | 2017-12-05 | Lockheed Martin Corporation | Syringe for obtaining nano-sized materials for selective assays and related methods of use |
US9107570B2 (en) | 2012-06-19 | 2015-08-18 | Covidien Lp | System and method for mapping anatomical structures and marking them on a substrate |
FR2992662B1 (en) | 2012-06-28 | 2014-08-08 | Sofradim Production | KNIT WITH PICOTS |
FR2992547B1 (en) | 2012-06-29 | 2015-04-24 | Sofradim Production | PROSTHETIC FOR HERNIA |
US9078786B1 (en) | 2012-10-19 | 2015-07-14 | Denise H. Miller | Methods and devices for collecting body fluids |
WO2014113724A2 (en) | 2013-01-17 | 2014-07-24 | Sharma Virender K | Method and apparatus for tissue ablation |
EP2950873B1 (en) | 2013-02-01 | 2019-09-04 | Boston Scientific Scimed, Inc. | Devices for fallopian tube diagnostics |
US10639016B2 (en) | 2013-02-01 | 2020-05-05 | Boston Scientific Scimed, Inc. | Methods and devices for Fallopian tube diagnostics |
WO2014164621A1 (en) | 2013-03-12 | 2014-10-09 | Lockheed Martin Corporation | Method for forming filter with uniform aperture size |
US9572918B2 (en) | 2013-06-21 | 2017-02-21 | Lockheed Martin Corporation | Graphene-based filter for isolating a substance from blood |
US9364638B2 (en) | 2014-01-21 | 2016-06-14 | Cook Medical Technologies Llc | Adjustable vaginal anchor for uterine tamponade device and methods of using the same |
CN105940479A (en) | 2014-01-31 | 2016-09-14 | 洛克希德马丁公司 | Methods for perforating two-dimensional materials using a broad ion field |
EP3099645A4 (en) | 2014-01-31 | 2017-09-27 | Lockheed Martin Corporation | Processes for forming composite structures with a two-dimensional material using a porous, non-sacrificial supporting layer |
CN106232205A (en) | 2014-03-12 | 2016-12-14 | 洛克希德马丁公司 | The separation film formed by porose Graphene |
CN105078642B (en) * | 2014-05-14 | 2018-07-24 | 吴江永元生物科技有限公司 | A kind of uterus implant |
US10179019B2 (en) | 2014-05-22 | 2019-01-15 | Aegea Medical Inc. | Integrity testing method and apparatus for delivering vapor to the uterus |
EP3145425A4 (en) | 2014-05-22 | 2018-02-14 | Aegea Medical, Inc. | Systems and methods for performing endometrial ablation |
US10624727B2 (en) * | 2014-06-26 | 2020-04-21 | Ipengine Management (India) Private Limited | Medical implants and fabrication of medical implants |
AU2015311978A1 (en) | 2014-09-02 | 2017-05-11 | Lockheed Martin Corporation | Hemodialysis and hemofiltration membranes based upon a two-dimensional membrane material and methods employing same |
US9636144B2 (en) | 2014-10-09 | 2017-05-02 | Coopersurgical, Inc. | Uterine manipulators and related components and methods |
US9782549B2 (en) | 2014-10-22 | 2017-10-10 | Ethicon, Inc. | Distance indicators for medicinal spray devices |
US20180000517A1 (en) * | 2014-10-22 | 2018-01-04 | Jmd Innovation Inc. | Anti-adhesion intrauterine balloon |
US20180140640A1 (en) * | 2015-04-22 | 2018-05-24 | Cadens Beheer B.V. | Improved contraceptive methods and compositions and devices for use therein |
MX2018001559A (en) | 2015-08-06 | 2018-09-27 | Lockheed Corp | Nanoparticle modification and perforation of graphene. |
EP3416551B1 (en) | 2016-02-19 | 2022-10-12 | Aegea Medical Inc. | Apparatus for determining the integrity of a bodily cavity |
JP2019521055A (en) | 2016-04-14 | 2019-07-25 | ロッキード・マーチン・コーポレーション | Selective interface relaxation of graphene defects |
CA3020686A1 (en) | 2016-04-14 | 2017-10-19 | Lockheed Martin Corporation | Method for treating graphene sheets for large-scale transfer using free-float method |
WO2017180134A1 (en) | 2016-04-14 | 2017-10-19 | Lockheed Martin Corporation | Methods for in vivo and in vitro use of graphene and other two-dimensional materials |
SG11201808961QA (en) | 2016-04-14 | 2018-11-29 | Lockheed Corp | Methods for in situ monitoring and control of defect formation or healing |
EP3442786A4 (en) | 2016-04-14 | 2020-03-18 | Lockheed Martin Corporation | Two-dimensional membrane structures having flow passages |
WO2017184669A1 (en) * | 2016-04-20 | 2017-10-26 | Duke University | Intrauterine adhesion barrier device and method of use |
US11331140B2 (en) | 2016-05-19 | 2022-05-17 | Aqua Heart, Inc. | Heated vapor ablation systems and methods for treating cardiac conditions |
CN106344230A (en) * | 2016-08-18 | 2017-01-25 | 马安军 | Anti-intrauterine adhesion device |
US11517336B2 (en) | 2016-08-24 | 2022-12-06 | Alydia Health, Inc. | Uterine hemorrhage controlling system and method |
CN107174321A (en) * | 2017-06-23 | 2017-09-19 | 西安美佳家医疗科技有限责任公司 | A kind of anti-sticking connected device for entering uterine cavity Automatic-expanding by opening of the cervix |
US11141308B2 (en) | 2017-08-31 | 2021-10-12 | Crossbay Medical, Inc. | Apparatus and method for everting catheter for IUD delivery and placement in the uterine cavity |
JP7319782B2 (en) * | 2018-01-15 | 2023-08-02 | マリナー エンドサージャリー インク. | Organ retention devices and systems, and their application to laparoscopic surgery |
US10932819B2 (en) | 2018-04-18 | 2021-03-02 | Coopersurgical, Inc. | Uterine manipulators and related components and methods |
BR112020021682A2 (en) * | 2018-04-25 | 2022-06-07 | Innomed Five L L C | Medical device and method for improving implantation of a fertilized egg during pregnancy |
WO2019211832A1 (en) * | 2018-04-30 | 2019-11-07 | Ocon Medical Ltd. | Localized delivery of an active agent |
WO2019232432A1 (en) | 2018-06-01 | 2019-12-05 | Santa Anna Tech Llc | Multi-stage vapor-based ablation treatment methods and vapor generation and delivery systems |
US11717656B2 (en) | 2019-03-20 | 2023-08-08 | Gyros ACMI Inc. | Delivery of mixed phase media for the treatment of the anatomy |
KR102260999B1 (en) * | 2019-03-27 | 2021-06-04 | (주)엠케어코리아 | Implant for ovarian cancer examination, examination kit including the same, and ovarian cancer screening method using the same |
EP3925544A1 (en) * | 2020-06-16 | 2021-12-22 | Arthrex Inc | Suture device |
PL436172A1 (en) | 2020-11-30 | 2022-06-06 | Szpital Specjalistyczny Pro-Familia Spółka Z Ograniczoną Odpowiedzialnością Spółka Komandytowa | Manipulator |
WO2022238756A1 (en) * | 2021-05-11 | 2022-11-17 | Dabiryan Hadi | Fabrication of textile-based capsules |
Family Cites Families (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US560600A (en) * | 1896-05-19 | Weighing-machine | ||
US1327786A (en) * | 1918-04-15 | 1920-01-13 | Charles H Stephan | Medical appliance |
US2888917A (en) * | 1954-09-08 | 1959-06-02 | Radium Service Corp Of America | Cervico-vaginal radium applicator |
CH477873A (en) * | 1967-07-14 | 1969-09-15 | Apamed Anst | Intrauterine contraceptive device |
US3845761A (en) * | 1970-06-02 | 1974-11-05 | Alza Corp | Intrauterine contraceptive anti-fertility device for the management of reproduction |
US3703896A (en) * | 1970-12-29 | 1972-11-28 | Abcor Inc | Intrauterine contraceptive device |
US3789838A (en) * | 1971-02-19 | 1974-02-05 | E Fournier | Force transmitting intrauterine device |
US3802425A (en) * | 1971-10-14 | 1974-04-09 | T Moulding | Intrauterine contraceptive device |
US3918443A (en) * | 1971-10-20 | 1975-11-11 | Ethyl Corp | Method for birth control |
US3905360A (en) * | 1971-11-01 | 1975-09-16 | Alza Corp | Intrauterine device for governing the reproductive process |
US3867933A (en) * | 1973-03-06 | 1975-02-25 | Tecna Corp | Intrauterine device and process of making the same |
US4111196A (en) * | 1973-07-27 | 1978-09-05 | Lionel C. R. Emmett | Intrauterine contraceptive device of c or omega form with tubular inserter and method of placement |
US3923051A (en) * | 1974-03-18 | 1975-12-02 | Samuel Soichet | Inflatable intrauterine contraceptive device for postpartum use |
US3952737A (en) * | 1974-08-28 | 1976-04-27 | The Medevice Company | Contraceptive |
US4117838A (en) * | 1976-09-02 | 1978-10-03 | Hasson Harrith M | Intrauterine contraceptive device |
US4284074A (en) * | 1978-07-26 | 1981-08-18 | Shaw Jr Seth T | IUD Arrangement |
US4359046A (en) * | 1979-07-09 | 1982-11-16 | Shaw Jr Seth T | IUD Arrangement |
JPS6014861A (en) * | 1983-07-05 | 1985-01-25 | 株式会社日本メデイカル・サプライ | Adhesion preventing material |
US4616640A (en) * | 1983-11-14 | 1986-10-14 | Steven Kaali | Birth control method and device employing electric forces |
US4583542A (en) * | 1984-10-11 | 1986-04-22 | Boyd Zane R | Hemorrhoidal pessary |
US4841991A (en) * | 1987-09-03 | 1989-06-27 | Nauchno-Proizvodstvennoe Obiedinenie "Medinstrument" | Intrauterine contraceptive device |
US4946818A (en) * | 1988-04-05 | 1990-08-07 | General Electric Company | Rhodium colloid, method of making, and use |
US4846818A (en) * | 1988-05-17 | 1989-07-11 | Conceptus, Inc. | Incontinence appliance |
US5146931A (en) * | 1988-08-15 | 1992-09-15 | Kurz Karl Heinz | Device to be placed in the uterus |
BE1002600A3 (en) * | 1988-11-23 | 1991-04-09 | Wildemeersch Dirk | IMPROVED INTRA-UTERINE DEVICE. |
US5095917A (en) * | 1990-01-19 | 1992-03-17 | Vancaillie Thierry G | Transuterine sterilization apparatus and method |
US5391146A (en) * | 1993-06-24 | 1995-02-21 | Conceptus, Inc. | Mechanism for manipulating the distal end of a biomedical device |
AU7115294A (en) * | 1993-06-24 | 1995-01-24 | Conceptus, Inc. | Guidewire-type device axially moveable by torque or axial force and methods for use thereof |
GB9315473D0 (en) * | 1993-07-27 | 1993-09-08 | Chemring Ltd | Treatment apparatus |
NL9400410A (en) * | 1994-03-16 | 1995-11-01 | M D Ph D Willem Arthur Adriaan | Intrauterine contraceptive. |
US6693077B1 (en) * | 1995-02-14 | 2004-02-17 | Human Genome Sciences, Inc. | Keratinocyte growth factor-2 |
US6705323B1 (en) * | 1995-06-07 | 2004-03-16 | Conceptus, Inc. | Contraceptive transcervical fallopian tube occlusion devices and methods |
US6176240B1 (en) * | 1995-06-07 | 2001-01-23 | Conceptus, Inc. | Contraceptive transcervical fallopian tube occlusion devices and their delivery |
US5601600A (en) * | 1995-09-08 | 1997-02-11 | Conceptus, Inc. | Endoluminal coil delivery system having a mechanical release mechanism |
US5947958A (en) * | 1995-09-14 | 1999-09-07 | Conceptus, Inc. | Radiation-transmitting sheath and methods for its use |
US5716321A (en) * | 1995-10-10 | 1998-02-10 | Conceptus, Inc. | Method for maintaining separation between a falloposcope and a tubal wall |
US5704899A (en) * | 1995-10-10 | 1998-01-06 | Conceptus, Inc. | Protective sheath for a fiberoptic image guide within an articulated endoscope |
US5807239A (en) * | 1996-05-17 | 1998-09-15 | Conceptus, Inc. | Transcervical ostium access device and method |
US5711958A (en) * | 1996-07-11 | 1998-01-27 | Life Medical Sciences, Inc. | Methods for reducing or eliminating post-surgical adhesion formation |
US6440445B1 (en) * | 1996-09-30 | 2002-08-27 | Brigham & Women's Hospital | Methods and compounds for treatment of abnormal uterine bleeding |
US5935098A (en) * | 1996-12-23 | 1999-08-10 | Conceptus, Inc. | Apparatus and method for accessing and manipulating the uterus |
US6080129A (en) * | 1996-12-23 | 2000-06-27 | Conceptus, Inc. | Method and apparatus for performing hysterosalpingography |
US5891457A (en) * | 1997-05-12 | 1999-04-06 | Neuwirth; Robert S. | Intrauterine chemical necrosing method, composition, and apparatus |
US6071283A (en) * | 1997-06-06 | 2000-06-06 | Medical Scientific, Inc. | Selectively coated electrosurgical instrument |
US6080152A (en) * | 1998-06-05 | 2000-06-27 | Medical Scientific, Inc. | Electrosurgical instrument |
US6309384B1 (en) * | 1999-02-01 | 2001-10-30 | Adiana, Inc. | Method and apparatus for tubal occlusion |
US6090997A (en) * | 1999-02-10 | 2000-07-18 | University Of Florida | Method and composition for preventing surgical adhesions and tissue damage employing fluorinated polymers |
US6211217B1 (en) * | 1999-03-16 | 2001-04-03 | Novartis Ag | Method for reducing pericardial fibrosis and adhesion formation |
US6709667B1 (en) * | 1999-08-23 | 2004-03-23 | Conceptus, Inc. | Deployment actuation system for intrafallopian contraception |
US6673071B2 (en) * | 2000-02-24 | 2004-01-06 | Vandusseldorp Gregg A. | Partial ablation procedure and device therefor |
US20050171569A1 (en) * | 2000-04-25 | 2005-08-04 | Impres Medical, Inc. | Method and apparatus for creating intrauterine adhesions |
EP1278480A2 (en) * | 2000-04-25 | 2003-01-29 | Impres Medical, Inc. | Method and apparatus for creating intrauterine adhesions |
US6395012B1 (en) * | 2000-05-04 | 2002-05-28 | Inbae Yoon | Apparatus and method for delivering and deploying an expandable body member in a uterine cavity |
US6685626B2 (en) * | 2001-02-02 | 2004-02-03 | Regeneration Technologies, Inc. | Compositions, devices, methods, and kits for induction of adhesions |
SE0200269D0 (en) * | 2002-01-31 | 2002-01-31 | Ellem Bioteknik Ab | Material for implantation |
WO2006028431A1 (en) * | 2003-05-21 | 2006-03-16 | Impres Medical, Inc. | Intrauterine implant and methods of use |
US20060089658A1 (en) * | 2004-10-21 | 2006-04-27 | Harrington Douglas C | Method and apparatus for treating abnormal uterine bleeding |
-
2001
- 2001-04-24 EP EP01930704A patent/EP1278480A2/en not_active Withdrawn
- 2001-04-24 WO PCT/US2001/013169 patent/WO2001080788A2/en active Application Filing
- 2001-04-24 AU AU2001257212A patent/AU2001257212B9/en not_active Ceased
- 2001-04-24 US US09/840,951 patent/US6708056B2/en not_active Expired - Lifetime
- 2001-04-24 CA CA2405710A patent/CA2405710C/en not_active Expired - Lifetime
- 2001-04-24 JP JP2001577891A patent/JP4503208B2/en not_active Expired - Fee Related
-
2003
- 2003-12-03 US US10/726,433 patent/US7320325B2/en not_active Expired - Lifetime
- 2003-12-22 US US10/744,506 patent/US20040193043A1/en not_active Abandoned
- 2003-12-22 US US10/745,078 patent/US7406969B2/en not_active Expired - Lifetime
-
2006
- 2006-12-20 AU AU2006252147A patent/AU2006252147B2/en not_active Ceased
-
2008
- 2008-07-03 US US12/167,862 patent/US20080264423A1/en not_active Abandoned
-
2009
- 2009-01-26 JP JP2009014806A patent/JP2009101190A/en active Pending
-
2011
- 2011-04-08 JP JP2011086839A patent/JP2011156379A/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
AU2001257212B2 (en) | 2006-09-21 |
AU2001257212B9 (en) | 2007-03-29 |
US7320325B2 (en) | 2008-01-22 |
US20040152978A1 (en) | 2004-08-05 |
US20040152977A1 (en) | 2004-08-05 |
JP2011156379A (en) | 2011-08-18 |
US20020010457A1 (en) | 2002-01-24 |
US20040193043A1 (en) | 2004-09-30 |
AU2006252147B2 (en) | 2008-02-14 |
JP2009101190A (en) | 2009-05-14 |
US7406969B2 (en) | 2008-08-05 |
EP1278480A2 (en) | 2003-01-29 |
WO2001080788A2 (en) | 2001-11-01 |
US6708056B2 (en) | 2004-03-16 |
WO2001080788A3 (en) | 2002-07-18 |
JP4503208B2 (en) | 2010-07-14 |
US20080264423A1 (en) | 2008-10-30 |
CA2405710C (en) | 2010-04-20 |
JP2004511269A (en) | 2004-04-15 |
AU5721201A (en) | 2001-11-07 |
AU2006252147A1 (en) | 2007-01-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2405710A1 (en) | Method and apparatus for creating intrauterine adhesions | |
EP2194939B1 (en) | Device for occluding an ovarian pathway | |
US20050033163A1 (en) | Intrauterine implant and methods of use | |
AU767864B2 (en) | Method and apparatus for tubal occlusion | |
AU2009300354B2 (en) | Porous bioabsorbable implant | |
KR20160045802A (en) | Surgical implant | |
CA2782044A1 (en) | Adhesive delivery devices, systems and methods | |
AU2001257212A1 (en) | Method and apparatus for creating intrauterine adhesions | |
CN116898637A (en) | Flexible bone particle bone grafting net bag and manufacturing method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKEX | Expiry |
Effective date: 20210426 |